Treace Medical Concepts, Inc. Marketable Securities, Unrealized Gain (Loss)
Treace Medical Concepts, Inc. (TMCI) reported Marketable Securities, Unrealized Gain (Loss) of -$26.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-08-07
- Treace Medical Concepts, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2026-06-30 was -$26.00K.
- Treace Medical Concepts, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2026-03-31 was -$98.00K.
- Treace Medical Concepts, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2025-12-31 was -$11.00K.
- Treace Medical Concepts, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2025-09-30 was $33.00K, a 84.79% decline year-over-year.
- Treace Medical Concepts, Inc. marketable securities, unrealized gain (loss) for fiscal 2025 was -$25.00K.
- Treace Medical Concepts, Inc. marketable securities, unrealized gain (loss) for fiscal 2024 was -$66.00K, a 134.74% decline from fiscal 2023.
- Treace Medical Concepts, Inc. marketable securities, unrealized gain (loss) for fiscal 2023 was $190.00K.
- Treace Medical Concepts, Inc. marketable securities, unrealized gain (loss) for fiscal 2022 was -$27.00K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$26.00K 10-Q · filed 2026-08-07 | -$124.00K 10-Q · filed 2026-08-07 | -$135.00K derived: sum of 3 quarters · filed 2026-08-07 | -$102.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$98.00K 10-Q · filed 2026-05-08 | -$109.00K derived: sum of 2 quarters · filed 2026-05-08 | -$76.00K derived: sum of 3 quarters · filed 2026-05-08 | -$83.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $22.00K derived: sum of 2 quarters · filed 2026-02-27 | $15.00K derived: sum of 3 quarters · filed 2026-08-07 | -$25.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $33.00K 10-Q · filed 2025-11-06 | $26.00K derived: sum of 2 quarters · filed 2026-08-07 | -$14.00K 10-Q · filed 2025-11-06 | -$108.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$7.00K 10-Q · filed 2026-08-07 | -$47.00K 10-Q · filed 2026-08-07 | -$141.00K derived: sum of 3 quarters · filed 2026-08-07 | $76.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$40.00K 10-Q · filed 2026-05-08 | -$134.00K derived: sum of 2 quarters · filed 2026-05-08 | $83.00K derived: sum of 3 quarters · filed 2026-05-08 | -$12.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $123.00K derived: sum of 2 quarters · filed 2026-02-27 | $28.00K derived: sum of 3 quarters · filed 2026-02-27 | -$66.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $217.00K 10-Q · filed 2025-11-06 | $122.00K derived: sum of 2 quarters · filed 2025-11-06 | $28.00K 10-Q · filed 2025-11-06 | $339.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$95.00K 10-Q · filed 2025-08-07 | -$189.00K 10-Q · filed 2025-08-07 | $122.00K derived: sum of 3 quarters · filed 2026-02-27 | $193.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$94.00K 10-Q · filed 2025-05-08 | $217.00K derived: sum of 2 quarters · filed 2026-02-27 | $288.00K derived: sum of 3 quarters · filed 2026-02-27 | $125.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $311.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $382.00K derived: sum of 2 quarters · filed 2026-02-27 | $219.00K derived: sum of 3 quarters · filed 2026-02-27 | $190.00K 10-K · filed 2026-02-27 |
| 2023-09-30 | $71.00K 10-Q · filed 2024-11-05 | -$92.00K derived: sum of 2 quarters · filed 2024-11-05 | -$121.00K 10-Q · filed 2024-11-05 | -$148.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$163.00K 10-Q · filed 2024-08-06 | -$192.00K 10-Q · filed 2024-08-06 | -$219.00K derived: sum of 3 quarters · filed 2025-02-27 | -$219.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$29.00K 10-Q · filed 2024-05-07 | -$56.00K derived: sum of 2 quarters · filed 2025-02-27 | -$56.00K derived: sum of 3 quarters · filed 2025-02-27 | -$56.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$27.00K derived: sum of 2 quarters · filed 2025-02-27 | -$27.00K derived: sum of 3 quarters · filed 2025-02-27 | -$27.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-27 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |